Clinical Trials Logo

Filter by:
NCT ID: NCT02963506 Completed - Clinical trials for Ankylosing Spondylitis

A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis

BE AGILE
Start date: October 2016
Phase: Phase 2
Study type: Interventional

This is a study to evaluate the efficacy and safety of different doses of bimekizumab in subjects with active Ankylosing Spondylitis (AS).

NCT ID: NCT02962986 Completed - Hypotension Clinical Trials

A Comparison of Intermittent Intravenous Boluses of Phenylephrine and Norepinephrine to Prevent Spinal-induced Hypotension in Cesarean Deliveries

Start date: January 2017
Phase: N/A
Study type: Interventional

Hypotension is a very common complication of spinal anesthesia for cesarean delivery, and can have unwanted side effects on both mother and fetus if not treated promptly. Phenylephrine has been the drug of choice to treat this spinal-induced hypotension. Although phenylephrine is safe to use for this indication, it has been associated with reflex bradycardia and a reduction in cardiac output. Norepinephrine is a potent vasopressor used to treat hypotension in the critical care setting. Recent studies have looked at norepinephrine's use in the obstetric setting, and have shown that it can be used safely and also has favourable hemodynamic properties when compared to phenylephrine, with less bradycardia and less depression of cardiac output. The investigators recently conducted a study to determine the ED90 of norepinephrine, and now plan to compare bolus doses of phenylephrine to norepinephrine for treating hypotension following spinal anesthesia for cesarean section. The investigators hypothesize that norepinephrine, when given as a bolus to prevent post spinal hypotension, will result in around 70% relative decrease in the rate of bradycardia when compared to phenylephrine in patients undergoing elective cesarean delivery under spinal anesthesia.

NCT ID: NCT02962583 Completed - Obesity Clinical Trials

The Addition of Probiotic Consumption to a Nutritional Intervention and Caloric Restriction on Body Weight and Composition in Overweight Participants

Start date: January 2017
Phase: Phase 2
Study type: Interventional

Limited interventional human studies suggest that probiotic supplementation may be a beneficial strategy for promoting weight loss when added to a nutritional intervention via their effects on lipid absorption and metabolic signaling molecules. The purpose of this study is to evaluate the effects of addition of a probiotic supplementation to a weight loss intervention on body weight, body composition and overall health in overweight adults.

NCT ID: NCT02961218 Completed - Sickle Cell Anemia Clinical Trials

Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Pediatric and Young Adult Patients With Sickle Cell Anemia

Start date: April 5, 2017
Phase: Phase 2
Study type: Interventional

The study assesses the efficacy, safety and tolerability of ACZ885 (canakinumab) in pediatric and young adult patients with sickle cell anemia (SCA).

NCT ID: NCT02961205 Completed - Malnutrition Clinical Trials

Nutrition Supplementation in Cardiovascular Surgery Patients

NutriSuP-CVS
Start date: August 1, 2017
Phase: N/A
Study type: Interventional

This randomized controlled pilot study evaluates the use of oral nutritional supplementation in nutritionally at-risk cardiovascular surgery patients. The oral nutrition supplement is given for 30 days prior to surgery, continuing throughout their surgical hospitalization and ends at hospital discharge. Half of the participants will receive the oral nutritional supplement and the other half will not.

NCT ID: NCT02961179 Completed - Type2 Diabetes Clinical Trials

Dairy Products, Diabetes and Genetics

PRODIGE
Start date: January 2017
Phase: N/A
Study type: Interventional

This study will investigate the in-depth the benefits of dairy consumption on glucose metabolism in patients at risk of type 2 diabetes using novel genomics methodology.To do so, 33 individuals at risk of type 2 diabetes will be randomly subjected to an intervention study including a 6-week intensive dairy product consumption period and a 6-week dietary counselling period.

NCT ID: NCT02960763 Completed - Clinical trials for Major Depressive Disorder

Optimizing Outcomes of Treatment-Resistant Depression in Older Adults

OPTIMUM
Start date: February 24, 2017
Phase: Phase 4
Study type: Interventional

The purpose of this research study is to assess which antidepressants work the best in older adults who have treatment-resistant depression (TRD).

NCT ID: NCT02960425 Completed - Muscle Weakness Clinical Trials

Delivra Topical Creatine for Improving Muscular Power

Start date: October 2016
Phase: N/A
Study type: Interventional

Creatine is a nutritional supplement that is often ingested to improve exercise performance. The advent of a new product that is applied to the skin overlying muscle offers potential benefit, if the creatine can be targeted to specific muscles. The investigators are testing a novel creatine cream to determine the effects on human muscular performance. The investigators are assessing the acute application of two different doses of the creatine cream on muscular power (determined by knee extension).

NCT ID: NCT02960269 Completed - Clinical trials for Back Pain Lower Back Chronic

Interprofessional Management of Chronic Back Pain in Rural and Remote Setting: Use of Telehealth vs. Secure Laptop-based Videoconferencing

Start date: November 2016
Phase: N/A
Study type: Interventional

This pilot study will evaluate the impact and overall experience of an interprofessional chronic low back pain patient care approach for people in rural and remote areas using Telehealth technology compared to secure laptop based videoconferencing (Vidyo).

NCT ID: NCT02960243 Completed - Essential Tremor Clinical Trials

Deep Brain Stimulation for Voice Tremor: Left, Right, or Both Hemispheres?

EVT
Start date: August 2016
Phase: N/A
Study type: Interventional

Deep Brain Stimulation (DBS) is the gold standard treatment for Essential Tremor (ET). ET is a movement disorder which causes the arms, feet, fingers, head or voice to involuntarily shake. The DBS surgical procedure involves implanting an electrode deep within the brain which blocks damaging signals that cause the tremor. Essential Voice Tremor (EVT) is the vocal manifestation of ET and a number of individuals have both ET and EVT, and when these patients are implanted for their ET, their EVT symptoms are often also mitigated. This study aims to quantify the effects of DBS on EVT by testing on these ET+EVT patients. In addition to this, we hope to determine which hemisphere of the brain is responsible for larynx control: left or right.